Women’s Health Diagnostics Market | High Prevalence of Infectious Diseases in Women

Factors such as growing awareness about various health-related disorders among women, rising incidence of various chronic and lifestyle disorders in women, and high prevalence of infectious diseases such as HIV and hepatitis in women across the globe are driving the growth of the market.

The global women’s health diagnostics market is projected to reach USD 36.64 Billion by 2021 from USD 25.03 Billion in 2016, at a CAGR of around 7.9% during the forecast period.

Target Audience:

• Hospitals and Clinics
• Medical Research and Development (R&D) Companies
• Medical Device Companies
• Women Health Diagnostics Solutions’ Vendors
• Medical Device Manufacturers
• Imaging and Diagnostic Centers
• Market Research and Consulting Firms
• Venture Capitalists and Investors

To know about the assumptions considered for the study, download the pdf brochure

 

Women’s Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) – Forecast to 2021

Moreover, the increasing adoption of point-of-care diagnostic testing and the increasing number of diagnostic and imaging centers are also expected to play a major role in market growth. However, shortage of skilled laboratory technicians and high costs of diagnostics devices, tests, and procedures are hindering the growth of women health diagnostics market.

Scope of the Report:

The research report categorizes the women’s health diagnostics market into the following segments and subsegments:

Global women’s health diagnostics market, by application

• Breast Cancer Testing
  • Mammography Systems
  • Breast Cancer Tumor Marker Tests
  • Blood Chemistries and Blood Cell Count
  • Biopsies
  • Other Diagnostic Imaging Tests
• Infectious Disease Testing
  • Urinary Tract Infection Testing
  • MRSA Testing
  • Hepatitis Testing
  • Tuberculosis Testing
  • Other Infectious Disease Testing
• Cervical Cancer Testing
  • Pap Smear
  • HPV Testing
• Osteoporosis Testing
  • Bone Densitometry
  • In Vitro Blood Tests
• Sexually Transmitted Disease Testing
  • Chlamydia Trachomatis And Neisseria Gonorrhoeae (Ct/Ng) Testing
  • HIV Testing
  • Other Sexually Transmitted Diseases
• Prenatal Genetic Screening and Carrier Testing
  • Cystic Fibrosis
  • Down Syndrome and Edward Syndrome
  • TORCH Infections
  • Other Diseases
• Ultrasound
  • OB/GYN Imaging
  • Breast Imaging
• Pregnancy and Fertility Testing
  • Pregnancy Testing and Ovulation Prediction Kits
  • Lab-based Testing
  • Fertility Monitors
• Ovarian Cancer Testing
• Ovarian Cancer Tumor Marker Tests
• Diagnostic Imaging Tests
• Other Tests

Request for Sample Pages @https://www.marketsandmarkets.com/requestsampleNew.asp?id=128928901

 

What are the Women’s Health Diagnostics Market Segments?

The global market has been segmented, on the basis of applications, and end users. On the basis of application, the market is segmented into various segments, namely, osteoporosis testing, ovarian cancer testing, cervical cancer testing, breast cancer testing, pregnancy & ovulation testing, prenatal genetic screening & carrier testing, infectious disease testing, sexually transmitted disease testing, and ultrasound.

Leading market players and strategies adopted

The prominent players in this market are Siemens AG (Germany), Quest Diagnostics Inc. (U.S.), Hologic, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), PerkinElmer Inc. (U.S.), Alere Inc. (U.S.), GE Healthcare (U.S.), Becton, Dickinson and Company (BD) (U.S.), Abbott Laboratories (U.S.), bioMérieux SA (France), and Koninklijke Philips N.V. (Netherlands).

For more details, visit: https://www.marketsandmarkets.com/Market-Reports/womens-health-diagnostics-market-128928901.html